Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
U.K. Biotech Firm Raises Cash By Crowdsourcing
by Alex Scott
February 16, 2015
| A version of this story appeared in
Volume 93, Issue 7
Cell Therapy, a Cardiff, Wales-based start-up developing a stem cell medicine for repairing muscle damage caused by heart attacks, has raised just over $1 million via the crowdfunding website Crowdcube. The new shareholders collectively own just over 1% of the company, valuing it at about $114 million. Cell Therapy rejected offers from venture capital funds in favor of equity crowdfunding to maintain more control over the business. It is the third European biotech firm to successfully raise cash via crowdfunding in recent weeks.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter